Goldman Sachs’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-18,261
Closed -$204K 6506
2022
Q4
$204K Sell
18,261
-77,425
-81% -$750K ﹤0.01% 5297
2022
Q3
$538K Sell
95,686
-152
-0.2% -$952 ﹤0.01% 4920
2022
Q2
$415K Sell
95,838
-1,039
-1% -$5.91K ﹤0.01% 5217
2022
Q1
$1.13M Sell
96,877
-22,448
-19% -$267K ﹤0.01% 4724
2021
Q4
$2.18M Buy
119,325
+94,714
+385% +$1.2M ﹤0.01% 4184
2021
Q3
$292K Buy
24,611
+7,136
+41% +$104K ﹤0.01% 5513
2021
Q2
$300K Sell
17,475
-2,819
-14% -$53.6K ﹤0.01% 5527
2021
Q1
$371K Buy
20,294
+2,298
+13% +$48.2K ﹤0.01% 5311
2020
Q4
$339K Sell
17,996
-9,245
-34% -$199K ﹤0.01% 4828
2020
Q3
$575K Sell
27,241
-10,157
-27% -$237K ﹤0.01% 4409
2020
Q2
$1.08M Buy
+37,398
New +$1.13M ﹤0.01% 3895

Other funds holding OYST

Goldman Sachs's OYST Position: Q1 2023 in Review

Goldman Sachs sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 18,261 shares — an estimated $204K sold.

Goldman Sachs first reported a position in OYST in Q2 2020 and held it in 11 quarters. The position peaked at $2.18M in Q4 2021. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • Goldman Sachs reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Goldman Sachs sold 18,261 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $204K.
  • Goldman Sachs first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
  • Goldman Sachs's Oyster Point Pharma, Inc. Common Stock position peaked at $2.18M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.